Technical review meeting on country experiences in ARV toxicity surveillance

Sharing preliminary results and lessons learnt, identifying solutions

Date: 7 – 8 November 2013
Place: Geneva, Switzerland


Since 2011, WHO has supported piloting projects in toxicity surveillance for antiretroviral (ARV) drugs in five low- and middle-income countries. Two approaches have been field-tested; a targeted spontaneous reporting approach in four countries: Côte d’Ivoire, Kenya, Lao PDR and Viet Nam, and a cohort event monitoring approach in Tanzania. The five country pilots are part of a collaborative project by WHO and the Bill and Melinda Gates Foundation (BMGF) that aims at producing technical guidance and building country capacity on the surveillance of toxicity of ARV drugs. In 2013, full implementation of the pilot projects will be completed.

The technical review meeting took place to review progress and lessons learnt from the country experiences. The meeting brought together national implementers and WHO responsible officers from piloting countries and regional offices, national and international experts from partner organizations. See full information on the meeting, discussions held, conclusions and recommendations reached from the report posted below.

Meeting report

Presentations by WHO staff and representatives from international and national partners

Disclaimer: The presentations are provided for public information purposes only. The named authors alone are responsible for the views expressed.